SPY423.60-0.71 -0.17%
DIA343.08-2.04 -0.59%
IXIC14,124.38+54.96 0.39%

HC Wainwright & Co. Maintains Buy on Antares Pharma, Raises Price Target to $5

HC Wainwright & Co. analyst Oren Livnat maintains Antares Pharma (NASDAQ:ATRS) with a Buy and raises the price target from $4.5 to $5.

05/10/2021 06:32
HC Wainwright & Co. analyst Oren Livnat maintains Antares Pharma (NASDAQ:ATRS) with a Buy and raises the price target from $4.5 to $5.